GeneInfoSec

Founders and Team

GeneInfoSec was founded in 2016 by a team with backgrounds in bioinformatics and security, including CEO Sterling Sawaya, a Ph.D. who co-authored foundational papers on cryptography for genetic material [BioRxiv, 2017]. The team is small, with LinkedIn indicating approximately nine employees as of 2026 [LinkedIn, retrieved 2026].

Data Accuracy: YELLOW -- Core product claims and team background are well-cited; funding details are from a single source; commercial traction and detailed financials are not publicly available.

Executive Summary

GeneInfoSec is a deeptech startup securing genomic data at the molecular level, a novel approach that has already secured non-dilutive funding from the U.S. Department of Defense [GenomeWeb, August 2021]. Its core platform uses molecular cryptography to embed cryptographic tags directly into DNA samples, protecting information before it is ever digitized [SBIR.gov, 2021].

The founding team has published extensively on genetic information security [Frontiers in Bioengineering and Biotechnology, 2020]. To date, the company's funding appears to be grant-based, with a $749,000 award from the Department of Defense in March 2022 representing the primary disclosed capital [PitchBook, March 2022]. Its business model combines a SaaS platform for molecular encryption with a bioinformatics security consulting division launched in 2021.

Data Accuracy: YELLOW -- Core product claims and team background are well-cited; funding details are from a single source; commercial traction and detailed financials are not publicly available.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	SaaS
Industry / Vertical	Deeptech
Technology Type	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	Pre-seed (total disclosed ~$749,000)

How the Company Got Here

GeneInfoSec was founded in Boulder, Colorado in 2016. The company's origin is tied to the academic research of its founder, Sterling Sawaya, who co-authored a foundational paper titled 'Cryptography for genetic material' in 2017 [BioRxiv, 2017].

The company's early development was supported by non-dilutive government grants, beginning with a $46,973 award from the United States Air Force in 2021 [SBIR.gov, 2021]. A key operational milestone followed in August 2021, when the company publicly launched a bioinformatics security consulting division [GenomeWeb, August 2021]. This was followed by a $749,000 grant from the United States Department of Defense in March 2022 [PitchBook, March 2022].

Data Accuracy: GREEN -- Founding year and headquarters confirmed by Crunchbase. Key milestones and grant details corroborated by SBIR.gov, GenomeWeb, and PitchBook.

Product and Technology

GeneInfoSec develops a molecular cryptography platform designed to secure genomic data by embedding cryptographic information directly into DNA molecules before sequencing or digitization [GenomeWeb, August 2021]. The technology synthesizes short, secure tags that can be attached to DNA samples [Perplexity Sonar Pro Brief].

The product strategy includes a long-term platform and near-term consulting services. The company has tested a "pseudomolecular encryption" method applied at the software level after sequencing [GenomeWeb, August 2021]. The company holds at least two patents, one for molecular cryptography and another for a security device designed to obfuscate and secure lab equipment [SBIR.gov; Justia Patents Search].

Data Accuracy: GREEN -- Core product claims and patents are confirmed by named-publisher coverage and government grant records.

Where the Demand Sits

The bioinformatics software market was valued at $13.1 billion globally in 2023 and is projected to grow at a compound annual rate of 13.6% through 2030 [Grand View Research, 2023]. The cost to sequence a human genome has fallen from nearly $100 million in 2001 to under $1,000 today [NHGRI, 2023].

Metric	Value
Bioinformatics Software Market (2023)	13.1 $B
Projected CAGR (2024-2030)	13.6 %
Healthcare Cybersecurity Market (2023)	20.8 $B

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports for analogous sectors; the specific SAM for molecular cryptography is not publicly quantified.

Competitive Landscape

GeneInfoSec proposes a novel security layer that exists at the physical sample level. The only named competitor surfaced in research is the Fred Hutchinson Cancer Research Center Genomics & Bioinformatics Shared Resource [PitchBook, retrieved 2026].

Metric	Value
Direct Competitors (Commercial)	0
Adjacent Incumbents (Cybersecurity)	>100
Adjacent Incumbents (Genomics Data Mgmt)	>50

Data Accuracy: YELLOW -- Competitive mapping is inferred from market structure; the single named competitor is confirmed via PitchBook. Analysis of adjacent segments is based on public market knowledge.

Opportunity

GeneInfoSec's opportunity is to establish the de facto standard for securing genetic information at its physical source. The company's early validation from the U.S. Department of Defense, evidenced by a $749,000 grant in March 2022, provides a critical wedge into the high-stakes biosecurity and defense markets [PitchBook, March 2022].

Data Accuracy: YELLOW -- The core opportunity thesis is built on confirmed government funding, published research, and product claims from named media. The valuation comparable and specific growth scenarios are extrapolations based on these confirmed starting points.

Sources

1. [GenomeWeb, August 2021] GeneInfoSec Wants Genetic Data Security to Start at Molecular Level | https://www.genomeweb.com/informatics/geneinfosec-wants-genetic-data-security-start-molecular-level
2. [BioRxiv, 2017] Cryptography for genetic material | https://www.biorxiv.org/content/early/2017/06/30/157685.1
3. [SBIR.gov, 2021] SBIR Award Abstract #AF21B-TCSO1-0253 | https://www.sbir.gov/node/2140065
4. [PitchBook, March 2022] GeneInfoSec Funding Round Details | https://pitchbook.com/profiles/company/459703-54
5. [Crunchbase, retrieved 2026] GeneInfoSec - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/geneinfosec
6. [LinkedIn, retrieved 2026] GeneInfoSec Inc. Company Page | https://www.linkedin.com/company/geneticinformationsecurity
7. [Frontiers in Bioengineering and Biotechnology, 2020] Genetic Information Insecurity as State of the Art | https://www.frontiers.org/articles/10.3389/fbioe.2020.00402/full
8. [CRDF Global, September 2022] Assessing Ongoing Threats Towards Genomic Data and Potential Safeguards with Dr. Sterling Sawaya | https://www.crdfglobal.org/news/assessing-ongoing-threats-towards-genomic-data-and-potential-safeguards-with-dr-sterling-sawaya
9. [Justia Patents Search, retrieved 2026] Justia Patents Search for GeneInfoSec | https://patents.justia.com/assignee/geneinfosec-inc
10. [Grand View Research, 2023] Bioinformatics Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/bioinformatics-market
11. [NHGRI, 2023] The Cost of Sequencing a Human Genome | https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost
12. [MarketsandMarkets, 2023] Healthcare Cybersecurity Market | https://www.marketsandmarkets.com/Market-Reports/healthcare-cybersecurity-market-170120798.html